Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Lilling

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
General Pharmacology|July 1, 1993
Treatment of muscle damage, induced by high intracellular Ca2+, with calmodulin antagonistsR Beitner, G Lilling
Biochemical Medicine and Metabolic Biology|June 1, 1991
Altered allosteric properties of cytoskeleton-bound phosphofructokinase in muscle from mice with X chromosome-linked muscular dystrophy (mdx)G Lilling, R Beitner
The International Journal of Biochemistry|January 1, 1990
Decrease in cytoskeleton-bound phosphofructokinase in muscle induced by high intracellular calcium, serotonin and phospholipase A2 in vivoG Lilling, R Beitner
The International Journal of Biochemistry|January 1, 1984
Inhibition of mitochondrial and soluble hexokinase from various rat tissues by glucose 1,6-bisphosphateR Beitner, G Lilling
The International Journal of Biochemistry|January 1, 1984
Influence of bradykinin on glucose 1,6-bisphosphate and cyclic GMP levels and on the activities of glucose 1,6-bisphosphatase, phosphofructokinase and phosphoglucomutase in muscleH Frucht, G Lilling, R Beitner
Biochemical Medicine and Metabolic Biology|April 1, 1993
The dual effects of Ca2+ on binding of the glycolytic enzymes, phosphofructokinase and aldolase, to muscle cytoskeletonM Chen-Zion, G Lilling, R Beitner
Brain Research|October 8, 1993
Vasoactive intestinal peptide: a growth promoter in neuroblastoma cellsY Wollman, G Lilling, M N Goldstein, et al.
Biochemical Medicine|December 1, 1983
Age-dependent changes in glucose 1,6-bisphosphate levels and in the activities of glucose 1,6-bisphosphatase, and particulate hexokinase and 6-phosphogluconate dehydrogenase in rat skinR Beitner, G Lilling, H Frucht, et al.
Peptides|August 28, 1999
SNV, a lipophilic superactive VIP analog, acts through cGMP to promote neuronal survivalO Ashur-Fabian, O Perl, G Lilling, et al.
Cancer Investigation|July 4, 2002
Altered subcellular localization of p53 in estrogen-dependent and estrogen-independent breast cancer cellsG Lilling, J Nordenberg, V Rotter, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
General Pharmacology|July 1, 1993
Treatment of muscle damage, induced by high intracellular Ca2+, with calmodulin antagonistsR Beitner, G Lilling
Biochemical Medicine and Metabolic Biology|June 1, 1991
Altered allosteric properties of cytoskeleton-bound phosphofructokinase in muscle from mice with X chromosome-linked muscular dystrophy (mdx)G Lilling, R Beitner
The International Journal of Biochemistry|January 1, 1990
Decrease in cytoskeleton-bound phosphofructokinase in muscle induced by high intracellular calcium, serotonin and phospholipase A2 in vivoG Lilling, R Beitner
The International Journal of Biochemistry|January 1, 1984
Inhibition of mitochondrial and soluble hexokinase from various rat tissues by glucose 1,6-bisphosphateR Beitner, G Lilling
The International Journal of Biochemistry|January 1, 1984
Influence of bradykinin on glucose 1,6-bisphosphate and cyclic GMP levels and on the activities of glucose 1,6-bisphosphatase, phosphofructokinase and phosphoglucomutase in muscleH Frucht, G Lilling, R Beitner
Biochemical Medicine and Metabolic Biology|April 1, 1993
The dual effects of Ca2+ on binding of the glycolytic enzymes, phosphofructokinase and aldolase, to muscle cytoskeletonM Chen-Zion, G Lilling, R Beitner
Brain Research|October 8, 1993
Vasoactive intestinal peptide: a growth promoter in neuroblastoma cellsY Wollman, G Lilling, M N Goldstein, et al.
Biochemical Medicine|December 1, 1983
Age-dependent changes in glucose 1,6-bisphosphate levels and in the activities of glucose 1,6-bisphosphatase, and particulate hexokinase and 6-phosphogluconate dehydrogenase in rat skinR Beitner, G Lilling, H Frucht, et al.
Peptides|August 28, 1999
SNV, a lipophilic superactive VIP analog, acts through cGMP to promote neuronal survivalO Ashur-Fabian, O Perl, G Lilling, et al.
Cancer Investigation|July 4, 2002
Altered subcellular localization of p53 in estrogen-dependent and estrogen-independent breast cancer cellsG Lilling, J Nordenberg, V Rotter, et al.
Pageof 2